|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:atccode
|
A03 BB01
|
|
gptkbp:brand
|
gptkb:Buscopan
Scopolan
|
|
gptkbp:casnumber
|
149-64-4
|
|
gptkbp:chemical_formula
|
C17 H22 Br N
|
|
gptkbp:class
|
gptkb:Fullmetal_Alchemist
|
|
gptkbp:clinical_trial
|
Phase III trials
Phase IV trials
|
|
gptkbp:composed_by
|
extraction from plants
synthetic process
|
|
gptkbp:contraindication
|
gptkb:Ophthalmology
gptkb:myasthenia_gravis
urinary retention
prostatic hypertrophy
|
|
gptkbp:discovered_by
|
gptkb:20th_century
|
|
gptkbp:dissolved
|
soluble in water
soluble in alcohol
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:form
|
gptkb:tablet
injection
suppository
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Hyoscine Butylbromide
|
|
gptkbp:interacts_with
|
antihistamines
antidepressants
opioids
|
|
gptkbp:legal_status
|
prescription only
|
|
gptkbp:lifespan
|
3-4 hours
|
|
gptkbp:mechanism_of_action
|
anticholinergic agent
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:p_hlevel
|
10.4
|
|
gptkbp:related_to
|
gptkb:scopolamine
|
|
gptkbp:route_of_administration
|
oral
intravenous
intramuscular
|
|
gptkbp:side_effect
|
dizziness
constipation
dry mouth
blurred vision
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:trade
|
gptkb:Buscopan
Drotaverine
Scopolan
|
|
gptkbp:used_for
|
abdominal pain
irritable bowel syndrome
spasms of the gastrointestinal tract
|
|
gptkbp:bfsParent
|
gptkb:scopolamine
|
|
gptkbp:bfsLayer
|
4
|